Suspension of trading
Lords & Company Worldwide Holdings Inc. Stock Canadian Securities Exchange
Stocks
LRDS
CA54404Q2009
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-.--% | - |
| Market Cap | 94.9K 82.94K 76.53K 70.54K 133K 9.14M 136K 915K 360K 4.48M 356K 349K 15.41M | P/E 2021 |
-1.31x | P/E 2022 | -0.72x |
|---|---|---|---|---|---|
| Enterprise Value | -59.11K -51.66K -47.67K -43.94K -82.82K -5.69M -84.65K -570K -224K -2.79M -222K -217K -9.6M | EV / Sales 2021 |
-
| EV / Sales 2022 | 459,754x |
| Free-Float |
99.84% | Yield 2021 * |
-
| Yield 2022 | - |
| 5 years | 0 | 1.5 | |
| 10 years | 0 | 7.2 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 57 | ||
| -1.32% | +5.33% | -8.55% | -5.18% | 13.54B | ||
| -3.30% | +9.97% | -27.67% | -49.81% | 5.27B | ||
| -2.47% | +7.14% | +0.62% | -4.09% | 4.72B | ||
| -5.06% | +6.38% | +8.55% | -32.43% | 4.07B | ||
| -2.65% | +2.32% | +4.01% | -8.76% | 3.75B | ||
| 0.00% | +9.56% | -4.89% | -3.35% | 3.57B | ||
| -3.45% | +9.23% | -5.06% | +7.03% | 3.39B | ||
| -3.77% | +0.45% | -13.12% | -22.74% | 2.42B | ||
| -2.82% | +3.13% | -1.88% | +49.73% | 1.86B | ||
| Average | -2.48% | +2.57% | -5.33% | -7.73% | 4.73B | |
| Weighted average by Cap. | -2.43% | +3.08% | -6.55% | -10.97% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 2.84 2.48 2.29 2.11 3.98 273.75 4.07 27.4 10.78 134.07 10.68 10.44 461.55 |
| Net income | -3.26M -2.85M -2.63M -2.42M -4.56M -314M -4.66M -31.39M -12.35M -154M -12.23M -11.96M -529M | -1.47M -1.28M -1.18M -1.09M -2.06M -141M -2.1M -14.15M -5.57M -69.24M -5.51M -5.39M -238M |
| Net Debt | -4.53K -3.96K -3.66K -3.37K -6.35K -437K -6.49K -43.69K -17.19K -214K -17.02K -16.65K -736K | -154K -135K -124K -114K -216K -14.83M -221K -1.48M -584K -7.26M -578K -566K -25.01M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LRDSF Stock
- LRDS Stock
Select your edition
All financial news and data tailored to specific country editions
















